학술논문
Donor Single-dose Treatment with VEGFR-3 Antibody Reduces Acute Alloimmune Response by Targeting Lymphatic Endothelial Cell Activation.
Document Type
Abstract
Author
Source
Subject
Language
ISSN
1053-2498